PerpEquities

Equity · Healthcare

Is HCA Healthcare (HCA) tradable as a perp? Not yet

HCA Healthcare operates a network of hospitals and outpatient facilities across the US and England, offering medical, surgical, and specialized care.

Not yet listed on any perp exchange

No perpetual-futures venue lists HCA yet. We track it continuously; as soon as the first listing appears, this page becomes a full market page. Until then: fundamentals below and tradable alternatives.

Similar stocks already tradable as perps
REGNBSXMRNAVRTXISRGBIIB

Price chart

Interactive TradingView chart

TradingView symbol NYSE:HCA

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Company data

Company fundamentals

Updated 3h ago
Market cap
$92.6B
Updated 3h ago
Revenue
$78B
Trailing 12 months
Revenue growth
+4%
Next fiscal year
Profit margin
+8.8%
P/E
14.3
Peer P/E 24.0
Free cash flow
$6B
Trailing 12 months
More metrics
Net income
$6.8B
Trailing 12 months
P/S
1.2
Peer P/E
24.0
Similar listed perps
Revenue estimate
$78.5B
Next fiscal year
Earnings
2026-10-23
Revenue est. $19.3B · Updated 3h ago
Dividend
$0.78
2026-09-16

Fundamental detail

Annual + quarterly
Latest revenue$75.6B
Net margin+9.0%
Free cash flow$7.7B
Net debt$49.2B
2020$51.5B
2021$58.8B
2022$60.2B
2023$65B
2024$70.6B
2025$75.6B
PeriodRevenueGrowthNet incomeFCF
2020$51.5B0%$3.8B$6.4B
2021$58.8B+14%$7B$5.4B
2022$60.2B+3%$5.6B$4.1B
2023$65B+8%$5.2B$4.7B
2024$70.6B+9%$5.8B$5.6B
2025$75.6B+7%$6.8B$7.7B
PeriodGross marginOperating marginNet marginROEROA
2020+83.8%+14.1%+7.3%+656.3%+7.9%
2021+38.3%+16.5%+11.8%-745.6%+13.7%
2022+38.5%+15.0%+9.4%-203.9%+10.8%
2023+39.4%+14.8%+8.1%-295.5%+9.3%
2024+40.6%+14.9%+8.2%-230.5%+9.7%
2025+41.5%+15.8%+9.0%-112.6%+11.2%
PeriodCashDebtNet debtCurrent ratio
2020$1.8B$33.1B$31.3B1.42
2021$1.5B$36.7B$35.3B1.41
2022$908M$40.2B$39.3B1.38
2023$935M$41.9B$40.9B1.18
2024$1.9B$45.2B$43.3B1.08
2025$1B$50.2B$49.2B0.83
PeriodMarket capEnterprise valueP/SP/E
2020$55.8B$87.1B1.114.8
2021$83.1B$118.3B1.411.9
2022$69.7B$109B1.212.3
2023$73.7B$114.7B1.114.1
2024$77.6B$120.9B1.113.5
2025$107.7B$156.9B1.416.3
Q3 2024$17.5B
Q4 2024$18.3B
Q1 2025$18.3B
Q2 2025$18.6B
Q3 2025$19.2B
Q4 2025$19.5B
Q1 2026$19.1B
Q2 2026$20.2B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$17.5B+8%$1.3B$2.3B
Q4 2024$18.3B+6%$1.4B$1.3B
Q1 2025$18.3B+6%$1.6B$660M
Q2 2025$18.6B+6%$1.7B$3B
Q3 2025$19.2B+10%$1.6B$3.1B
Q4 2025$19.5B+7%$1.9B$870M
Q1 2026$19.1B+4%$1.6B$895M
Q2 2026$20.2B+9%$1.7B$1.1B
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+39.9%+13.8%+7.3%-58.2%+2.1%
Q4 2024+41.4%+15.6%+7.9%-57.5%+2.4%
Q1 2025+41.3%+15.6%+8.8%-45.8%+2.7%
Q2 2025+41.0%+15.9%+8.9%-37.6%+2.8%
Q3 2025+41.8%+15.5%+8.6%-30.8%+2.7%
Q4 2025+41.9%+16.3%+9.6%-31.2%+3.1%
Q1 2026+15.0%+15.0%+8.5%-25.7%+2.6%
Q2 2026+15.2%+15.2%+8.4%-25.8%+2.8%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$2.9B$44.9B$42B1.12
Q4 2024$1.9B$45.2B$43.3B1.08
Q1 2025$1.1B$46.4B$45.4B1.19
Q2 2025$939M$46.4B$45.4B0.98
Q3 2025$997M$46.3B$45.4B0.85
Q4 2025$1B$50.2B$49.2B0.83
Q1 2026$940M$49.8B$48.9B0.83
Q2 2026$1B$48.8B$47.8B0.78
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$105.6B$147.6B6.020.6
Q4 2024$75.7B$119B4.113.2
Q1 2025$86.2B$131.6B4.713.2
Q2 2025$92.7B$138.1B5.013.9
Q3 2025$103.3B$148.7B5.415.1
Q4 2025$107.7B$156.9B5.514.3
Q1 2026$107.3B$156.2B5.616.5
Q2 2026$86.9B$134.6B4.312.8

Refreshed 3h ago

Charts: revenue, profit, cash flow & valuation
Revenue$20.2BQ2 2026
$5.1B$10.1B$15.2B$20.2BQ3 2023: $16.2BQ4 2023: $17.3BQ1 2024: $17.3BQ2 2024: $17.5BQ3 2024: $17.5BQ4 2024: $18.3BQ1 2025: $18.3BQ2 2025: $18.6BQ3 2025: $19.2BQ4 2025: $19.5BQ1 2026: $19.1BQ2 2026: $20.2BQ3 2023Q2 2026
Net income$1.7BQ2 2026
$469.5M$939M$1.4B$1.9BQ3 2023: $1.1BQ4 2023: $1.6BQ1 2024: $1.6BQ2 2024: $1.5BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.6BQ2 2025: $1.7BQ3 2025: $1.6BQ4 2025: $1.9BQ1 2026: $1.6BQ2 2026: $1.7BQ3 2023Q2 2026
EBITDA$4BQ2 2026
$1B$2.1B$3.1B$4.2BQ3 2023: $2.9BQ4 2023: $3.6BQ1 2024: $3.6BQ2 2024: $3.6BQ3 2024: $3.3BQ4 2024: $3.5BQ1 2025: $3.7BQ2 2025: $3.8BQ3 2025: $3.9BQ4 2025: $4.2BQ1 2026: $3.8BQ2 2026: $4BQ3 2023Q2 2026
Free cash flow$1.1BQ2 2026
$782M$1.6B$2.3B$3.1BQ3 2023: $1.3BQ4 2023: $1.5BQ1 2024: $1.4BQ2 2024: $690MQ3 2024: $2.3BQ4 2024: $1.3BQ1 2025: $660MQ2 2025: $3BQ3 2025: $3.1BQ4 2025: $870MQ1 2026: $895MQ2 2026: $1.1BQ3 2023Q2 2026
EPS$7.62Q2 2026
$2.04$4.07$6.11$8.14Q3 2023: $3.89Q4 2023: $5.93Q1 2024: $5.94Q2 2024: $5.53Q3 2024: $4.89Q4 2024: $5.63Q1 2025: $6.45Q2 2025: $6.83Q3 2025: $6.96Q4 2025: $8.14Q1 2026: $7.15Q2 2026: $7.62Q3 2023Q2 2026
Cash / Debt$1BQ2 2026
$12.5B$25.1B$37.6B$50.2BQ3 2023 · Cash: $891MQ3 2023 · Debt: $41.1BQ4 2023 · Cash: $935MQ4 2023 · Debt: $41.9BQ1 2024 · Cash: $1.3BQ1 2024 · Debt: $42.1BQ2 2024 · Cash: $831MQ2 2024 · Debt: $42.8BQ3 2024 · Cash: $2.9BQ3 2024 · Debt: $44.9BQ4 2024 · Cash: $1.9BQ4 2024 · Debt: $45.2BQ1 2025 · Cash: $1.1BQ1 2025 · Debt: $46.4BQ2 2025 · Cash: $939MQ2 2025 · Debt: $46.4BQ3 2025 · Cash: $997MQ3 2025 · Debt: $46.3BQ4 2025 · Cash: $1BQ4 2025 · Debt: $50.2BQ1 2026 · Cash: $940MQ1 2026 · Debt: $49.8BQ2 2026 · Cash: $1BQ2 2026 · Debt: $48.8BQ3 2023Q2 2026
CashDebt
Profitability+15.2%Q2 2026
+21.3%+42.5%+63.8%+85.1%Q3 2023 · Gross margin: +85.1%Q4 2023 · Gross margin: +85.1%Q1 2024 · Gross margin: +84.6%Q2 2024 · Gross margin: +41.0%Q3 2024 · Gross margin: +39.9%Q4 2024 · Gross margin: +41.4%Q1 2025 · Gross margin: +41.3%Q2 2025 · Gross margin: +41.0%Q3 2025 · Gross margin: +41.8%Q4 2025 · Gross margin: +41.9%Q1 2026 · Gross margin: +15.0%Q2 2026 · Gross margin: +15.2%Q3 2023 · Operating margin: 0.0%Q4 2023 · Operating margin: +16.2%Q1 2024 · Operating margin: +14.8%Q2 2024 · Operating margin: +15.6%Q3 2024 · Operating margin: +13.8%Q4 2024 · Operating margin: +15.6%Q1 2025 · Operating margin: +15.6%Q2 2025 · Operating margin: +15.9%Q3 2025 · Operating margin: +15.5%Q4 2025 · Operating margin: +16.3%Q1 2026 · Operating margin: +15.0%Q2 2026 · Operating margin: +15.2%Q3 2023 · Net margin: +6.7%Q4 2023 · Net margin: +9.3%Q1 2024 · Net margin: +9.2%Q2 2024 · Net margin: +8.4%Q3 2024 · Net margin: +7.3%Q4 2024 · Net margin: +7.9%Q1 2025 · Net margin: +8.8%Q2 2025 · Net margin: +8.9%Q3 2025 · Net margin: +8.6%Q4 2025 · Net margin: +9.6%Q1 2026 · Net margin: +8.5%Q2 2026 · Net margin: +8.4%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+8.7%Q2 2026
+2.4%+4.8%+7.2%+9.6%Q3 2024: +7.9%Q4 2024: +5.7%Q1 2025: +5.7%Q2 2025: +6.4%Q3 2025: +9.6%Q4 2025: +6.7%Q1 2026: +4.3%Q2 2026: +8.7%Q3 2023Q2 2026
Shares outstanding222.8MQ2 2026
67.8M135.6M203.4M271.2MQ3 2023: 271.2MQ4 2023: 271.2MQ1 2024: 268MQ2 2024: 264.1MQ3 2024: 259.9MQ4 2024: 255.3MQ1 2025: 249.4MQ2 2025: 241.9MQ3 2025: 242.5MQ4 2025: 230.7MQ1 2026: 226.7MQ2 2026: 222.8MQ3 2023Q2 2026
Valuation12.8Q2 2026
5.110.315.420.6Q3 2023 · P/E: 15.7Q4 2023 · P/E: 11.2Q1 2024 · P/E: 13.7Q2 2024 · P/E: 14.1Q3 2024 · P/E: 20.6Q4 2024 · P/E: 13.2Q1 2025 · P/E: 13.2Q2 2025 · P/E: 13.9Q3 2025 · P/E: 15.1Q4 2025 · P/E: 14.3Q1 2026 · P/E: 16.5Q2 2026 · P/E: 12.8Q3 2023 · P/S: 4.0Q4 2023 · P/S: 4.2Q1 2024 · P/S: 5.0Q2 2024 · P/S: 4.7Q3 2024 · P/S: 6.0Q4 2024 · P/S: 4.1Q1 2025 · P/S: 4.7Q2 2025 · P/S: 5.0Q3 2025 · P/S: 5.4Q4 2025 · P/S: 5.5Q1 2026 · P/S: 5.6Q2 2026 · P/S: 4.3Q3 2023Q2 2026
P/EP/S
Revenue$75.6B2025
$18.9B$37.8B$56.7B$75.6B2018: $46.7B2019: $51.3B2020: $51.5B2021: $58.8B2022: $60.2B2023: $65B2024: $70.6B2025: $75.6B20182025
Net income$6.8B2025
$1.7B$3.5B$5.2B$7B2018: $3.8B2019: $3.5B2020: $3.8B2021: $7B2022: $5.6B2023: $5.2B2024: $5.8B2025: $6.8B20182025
EBITDA$15.6B2025
$3.9B$7.8B$11.7B$15.6B2018: $9.4B2019: $9.7B2020: $9.7B2021: $14.3B2022: $13.3B2023: $12.7B2024: $13.9B2025: $15.6B20182025
Free cash flow$7.7B2025
$1.9B$3.8B$5.8B$7.7B2018: $3.2B2019: $3.4B2020: $6.4B2021: $5.4B2022: $4.1B2023: $4.7B2024: $5.6B2025: $7.7B20182025
EPS$28.42025
$7.1$14.2$21.3$28.42018: $10.72019: $10.12020: $10.92021: $21.22022: $19.22023: $192024: $222025: $28.420182025
Cash / Debt$1B2025
$12.5B$25.1B$37.6B$50.2B2018 · Cash: $502M2018 · Debt: $32.8B2019 · Cash: $621M2019 · Debt: $35.6B2020 · Cash: $1.8B2020 · Debt: $33.1B2021 · Cash: $1.5B2021 · Debt: $36.7B2022 · Cash: $908M2022 · Debt: $40.2B2023 · Cash: $935M2023 · Debt: $41.9B2024 · Cash: $1.9B2024 · Debt: $45.2B2025 · Cash: $1B2025 · Debt: $50.2B20182025
CashDebt
Profitability+41.5%2025
+20.9%+41.9%+62.8%+83.8%2018 · Gross margin: +83.5%2019 · Gross margin: +83.5%2020 · Gross margin: +83.8%2021 · Gross margin: +38.3%2022 · Gross margin: +38.5%2023 · Gross margin: +39.4%2024 · Gross margin: +40.6%2025 · Gross margin: +41.5%2018 · Operating margin: +14.2%2019 · Operating margin: +14.1%2020 · Operating margin: +14.1%2021 · Operating margin: +16.5%2022 · Operating margin: +15.0%2023 · Operating margin: +14.8%2024 · Operating margin: +14.9%2025 · Operating margin: +15.8%2018 · Net margin: +8.1%2019 · Net margin: +6.8%2020 · Net margin: +7.3%2021 · Net margin: +11.8%2022 · Net margin: +9.4%2023 · Net margin: +8.1%2024 · Net margin: +8.2%2025 · Net margin: +9.0%20182025
Gross marginOperating marginNet margin
Revenue growth+7.1%2025
+3.5%+7.0%+10.5%+14.0%2019: +10.0%2020: +0.4%2021: +14.0%2022: +2.5%2023: +7.9%2024: +8.7%2025: +7.1%20182025
Shares outstanding230.7M2025
88.8M177.7M266.5M355.3M2018: 355.3M2019: 348.2M2020: 345.4M2021: 328.8M2022: 294.7M2023: 276.4M2024: 261.8M2025: 230.7M20182025
Valuation16.32025
4.18.212.216.32018 · P/E: 11.32019 · P/E: 14.42020 · P/E: 14.82021 · P/E: 11.92022 · P/E: 12.32023 · P/E: 14.12024 · P/E: 13.52025 · P/E: 16.32018 · P/S: 0.92019 · P/S: 1.02020 · P/S: 1.12021 · P/S: 1.42022 · P/S: 1.22023 · P/S: 1.12024 · P/S: 1.12025 · P/S: 1.420182025
P/EP/S

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202629.47$78.5B+4%15
FY 202732.05$81.6B+8%15
FY 202835.37$85.3B+13%12
FY 202939.24$91B+20%9
FY 203044.81$96.3B+27%5
Q1 20277.78$19.9B+4%5

Company events

6
2026-10-23EarningsActual - / Estimate 6.7-
2026-09-16Dividend$0.78-
2026-07-24EarningsActual 7.59 / Estimate 7.56Beat
2026-06-16Dividend$0.78-
2026-04-24EarningsActual 7.15 / Estimate 7.12Beat
2026-03-17Dividend$0.78-

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
REGN$80.8B5.218.7+27.9%6BSX$64.4B3.117.5+17.5%2MRNA$61.1B27.4-19.3-141.4%21VRTX$129B10.229.3+34.9%3ISRG$139B12.644.4+28.4%8BIIB$31.8B3.237.9+8.4%3PFE$157.3B2.536.5+6.8%3SMMT$14.2B--15.90.0%1

Analyst track record

How the analysts covering HCA have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings143367
Analysts2635
Buy / hold / sell91 / 48 / 4254 / 105 / 8
Upgrades / downgrades / initiations0 / 2 / 01 / 10 / 6
Price targets hit / missed29 / 103 (22%)211 / 121 (64%)
Avg. return after a rating (TipRanks)-10.1%+7.9%
Best / worst call+16.3% / -32.4%+68.9% / -32.4%

After buy calls on this stock: median 21-day move +6.2% vs S&P 500 +2.5% (n = 253)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Andrew Mok CFABarclays100% hit rate on this stock · 17 targets measuredHoldtarget $387Jul 26, 2026
  2. Ben HendrixRBC Capital100% hit rate on this stock · 15 targets measuredBuytarget $435Sep 7, 2026
  3. Whit MayoLeerink Partners100% hit rate on this stock · 14 targets measuredBuyno targetSep 17, 2026

Latest ratings

DateAnalystCallTarget
Sep 17, 2026Whit MayoLeerink PartnersBuyReiterated–article ↗
Sep 17, 2026Brian TanquilutJefferiesBuyMaintained$450article ↗
Sep 17, 2026Brian TanquilutJefferiesBuyMaintained$450
Sep 9, 2026Lance WilkesBernsteinHoldMaintained$426article ↗
Sep 7, 2026Ben HendrixRBC CapitalBuyMaintained$435article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$380$400$420$440$460$480$500$520$540Oct 25 · Buy 14 · Hold 11 · Sell 0Oct 25Nov 25 · Buy 14 · Hold 10 · Sell 0Dec 25 · Buy 14 · Hold 10 · Sell 0Dec 25Jan 26 · Buy 14 · Hold 7 · Sell 1Feb 26 · Buy 14 · Hold 6 · Sell 1Feb 26Mar 26 · Buy 14 · Hold 6 · Sell 1Apr 26 · Buy 12 · Hold 6 · Sell 1Apr 26May 26 · Buy 12 · Hold 6 · Sell 1Jun 26 · Buy 13 · Hold 6 · Sell 1Jun 26Jul 26 · Buy 13 · Hold 7 · Sell 1Aug 26 · Buy 14 · Hold 7 · Sell 1Aug 26Sep 26 · Buy 14 · Hold 7 · Sell 1Oct 25 · avg. target $476Nov 25 · avg. target $475Dec 25 · avg. target $477Jan 26 · avg. target $513Feb 26 · avg. target $533Mar 26 · avg. target $534Apr 26 · avg. target $523May 26 · avg. target $519Jun 26 · avg. target $509Jul 26 · avg. target $459Aug 26 · avg. target $459Sep 26 · avg. target $459Oct 25 · month-end close $460Nov 25 · month-end close $508Dec 25 · month-end close $467Jan 26 · month-end close $488Feb 26 · month-end close $530Mar 26 · month-end close $473Apr 26 · month-end close $434May 26 · month-end close $379Jun 26 · month-end close $390Jul 26 · month-end close $403Aug 26 · month-end close $414Sep 26 · month-end close $429

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Sep 18, 2026 · 143 ratings